Additionally, in head and neck cancer, evidence of diagnostic and therapeutic potential of FAPI ligands could be proven, although no histopathological DSR correlate or FAP IHC has been evaluated in upfront diagnostics [44]. This evidence concerns the gene FAP and head and neck cancer.